Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ertenli

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Rheumatology|November 2, 2004
The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patientsM Calguneri, S Apras, Z Ozbalkan, et al.
Rheumatology International|January 1, 1996
Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosisI Ertenli, I C Haznedaroğlu, S Kiraz, et al.
Annals of the Rheumatic Diseases|April 16, 2003
Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open studyM Calgüneri, M A Oztürk, I Ertenli, et al.
Clinical and Experimental Rheumatology|December 28, 1999
Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritisM Calgüneri, S Pay, Z Calişkaner, et al.
Clinical Rheumatology|October 28, 2003
The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosisM Calguneri, S Apras, Z Ozbalkan, et al.
The Journal of Rheumatology|June 19, 1998
P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosisI Ertenli, S Kiraz, M Arici, et al.
The Journal of Rheumatology|September 24, 1999
Circulating thrombopoietin in systemic sclerosisI Ertenli, S Kiraz, H Ertürk, et al.
Clinical and Experimental Rheumatology|January 5, 2002
Synovial fluid cytokine levels in Behçet's diseaseI Ertenli, S Kiraz, M Calgüneri, et al.
Annals of the Rheumatic Diseases|November 16, 2001
Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic stateI Ertenli, S Kiraz, I C Celik, et al.
The Journal of International Medical Research|September 11, 2003
Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosusM Calgüneri, M A Oztürk, Z Ozbalkan, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|November 2, 2004
The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patientsM Calguneri, S Apras, Z Ozbalkan, et al.
Rheumatology International|January 1, 1996
Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosisI Ertenli, I C Haznedaroğlu, S Kiraz, et al.
Annals of the Rheumatic Diseases|April 16, 2003
Effects of interferon alpha treatment on the clinical course of refractory Behçet's disease: an open studyM Calgüneri, M A Oztürk, I Ertenli, et al.
Clinical and Experimental Rheumatology|December 28, 1999
Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritisM Calgüneri, S Pay, Z Calişkaner, et al.
Clinical Rheumatology|October 28, 2003
The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosisM Calguneri, S Apras, Z Ozbalkan, et al.
The Journal of Rheumatology|June 19, 1998
P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosisI Ertenli, S Kiraz, M Arici, et al.
The Journal of Rheumatology|September 24, 1999
Circulating thrombopoietin in systemic sclerosisI Ertenli, S Kiraz, H Ertürk, et al.
Clinical and Experimental Rheumatology|January 5, 2002
Synovial fluid cytokine levels in Behçet's diseaseI Ertenli, S Kiraz, M Calgüneri, et al.
Annals of the Rheumatic Diseases|November 16, 2001
Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic stateI Ertenli, S Kiraz, I C Celik, et al.
The Journal of International Medical Research|September 11, 2003
Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosusM Calgüneri, M A Oztürk, Z Ozbalkan, et al.
Pageof 4